|
HS Code |
849570 |
| Product Name | 4-Bromo-1-Trityl-1H-Imidazole |
| Cas Number | 936940-54-8 |
| Molecular Formula | C22H17BrN2 |
| Molecular Weight | 389.29 g/mol |
| Appearance | White to off-white solid |
| Purity | Typically ≥98% |
| Melting Point | 153-157°C |
| Storage Temperature | 2-8°C |
| Solubility | Soluble in DMSO, DMF |
| Smiles | Brc1cncn1C(c2ccccc2)(c3ccccc3)c4ccccc4 |
| Inchikey | CXDXZJMNJOZOSM-UHFFFAOYSA-N |
As an accredited 4-Bromo-1-Trityl-1H-Imidazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass vial labeled "4-Bromo-1-Trityl-1H-Imidazole, 5 grams" with screw cap, lot number, and hazard information printed. |
| Shipping | **Shipping Description:** 4-Bromo-1-Trityl-1H-Imidazole is shipped in tightly sealed containers, protected from moisture and light. The chemical is packed to prevent breakage and contamination, and accompanied by appropriate safety documentation. Compliant with relevant regulations, it is sent via courier or freight, typically as a non-hazardous laboratory chemical unless otherwise specified. |
| Storage | 4-Bromo-1-Trityl-1H-Imidazole should be stored in a tightly closed container, in a cool, dry, and well-ventilated area, away from moisture, light, and incompatible substances such as strong oxidizing agents. Store at room temperature or as specified by the manufacturer. Ensure proper labeling and keep away from direct sunlight. Use appropriate personal protective equipment when handling the compound. |
Applications of 4-Bromo-1-Trityl-1H-Imidazole in Industrial Manufacturing4-Bromo-1-Trityl-1H-Imidazole serves as a key intermediate in organic synthesis across advanced chemical manufacturing. This specialty compound supports critical processes in pharmaceutical active pharmaceutical ingredient (API) production, specialty agrochemical synthesis, research-scale peptide modification, and pigment precursor manufacturing. Below we detail its downstream industrial applications, matched with compliance, usage ratio, process integration, and end products. 1. API Intermediate for Antiviral Drug Synthesis4-Bromo-1-Trityl-1H-Imidazole plays an essential role as a building block in nucleoside analog API synthesis, especially for antiviral product lines. The compound’s bromo-substitution allows precise regioselective reactions, enabling efficient attachment onto imidazole-ribose scaffolds under controlled conditions. Downstream manufacturers use this material for producing core structures in clinical pharmaceuticals targeting viral DNA/RNA polymerases. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Intermediate for Trityl-Imidazole Protected Peptide SynthesisPeptide manufacturers incorporate 4-Bromo-1-Trityl-1H-Imidazole into complex solid-phase peptide synthesis (SPPS) protocols. The trityl group provides orthogonal protection of the imidazole nitrogen, while the bromo substituent enables selective further derivatization. Process chemists select this material to achieve controlled assembly of biologically active imidazole-containing peptide chains. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Precursor in Specialty Agrochemical SynthesisAgrochemical formulators require 4-Bromo-1-Trityl-1H-Imidazole for production of imidazole-based bioactive compounds. The molecule’s dual functional groups support advanced heterocycle assembly in proprietary crop protection chemicals. Manufacturers rely on this intermediate for scalable and selective steps in fungicide and plant stimulant development pipelines. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Intermediate for Electronic Pigment and Dye SynthesisHighly pure 4-Bromo-1-Trityl-1H-Imidazole supports speciality pigment manufacturers producing advanced imidazole-based colorants for electronics and industrial coatings. Its structure permits efficient functionalization, enabling batch-syntheses of high-performance dyes used in OLEDs, electrophotographic materials, and specialty inkjet platforms. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 4-Bromo-1-Trityl-1H-Imidazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every chemical compound carries a story. For us as direct manufacturers, the journey with 4-Bromo-1-Trityl-1H-Imidazole has revolved around precision, customization, and the need for practical solutions in synthetic chemistry. Over the years, repeated requests from medicinal, academic, and process chemists led us to optimize the synthesis, purification, and delivery of this specialty molecule. Its chemical structure—combining the bromo-imidazole core with a trityl protecting group—came about not for fashion, but for real, grueling laboratory challenges. We witness time and again how this design enables new synthetic possibilities when traditional imidazole derivatives hit a roadblock.
Avoiding confusion starts with clear details. Our 4-Bromo-1-Trityl-1H-Imidazole features a distinct trityl group bound to the nitrogen atom. This tritylation step isn’t cosmetic; it transforms the reactivity of the molecule, allowing chemists to selectively protect and later deprotect imidazole nitrogens under controlled conditions. In our facility, we worked through dozens of recrystallization and chromatography protocols before settling on a reliable process that consistently delivers high-purity material—something the bench chemist notices at the first dissolve-and-weigh step.
In our current production, each batch is tested—by both NMR and HPLC—to confirm the bromo-position remains uncontaminated by isomeric byproducts. Subtle discoloration sometimes points to 4,5-dibromo contamination, which can sabotage downstream coupling or functional group transformations. We reject any lot that shows more than a trace. From experience, a molecule weighed in with 99%+ purity on paper still frustrates the synthetic sequence if residual trityl-free imidazole pops up. The actual feel and response of the compound in a reaction tells the real story, not just the specs on a sheet.
Our standard offering comes as white to faintly off-white crystalline powder. The batch-to-batch consistency comes from methodical, skilled purification—no off-the-shelf shortcuts. Moisture is kept low, down to the level demanded for Suzuki or Buchwald cross-couplings, where any stray water compromises yield. We watched over years as trace water destroyed expensive metal catalysts, and so invested in both extra drying time and fully sealed moisture-barrier packaging. We see each gram dispensed as the start of someone’s research—not just the end of our own process.
Chemists in pharma labs, academic departments, and process R&D gravitate to this molecule for a reason. Building heterocyclic scaffolds, especially in drug discovery, means moving beyond ordinary halogenated imidazoles. The trityl group lets chemists unlock selective functionalization at the remaining positions—changing a bland synthetic sequence into a precise, stepwise modification plan. Only a handful of imidazole derivatives give this level of control and resilience under the pH ranges demanded by modern cross-coupling protocols.
We’ve worked with clients who move from milligram bench work to kilo-scale batch production. The trityl protects the key nitrogen during harsh conditions, such as during Suzuki–Miyaura and Stille couplings. Tritylation saves sensitive intermediates from premature deprotection, oxidation, or rearrangement. Once the desired complexity is built, the group can be removed cleanly—restoring imidazole’s desired reactivity exactly when it’s needed. Our clients tell stories of project timelines shaved by weeks due to this control. We’re often asked how long the trityl persists under various acidic or basic conditions, and we’ve generated our own in-house data to guide process chemists in scaling or troubleshooting.
Comparing this molecule with more basic 4-bromoimidazoles shows the real benefits. Non-tritylated versions don’t survive multi-step synthesis; nitrogen sites wind up alkylated or react uncontrollably under mild or even ambient conditions. The trityl group stands as a guardian throughout reaction cascades that could otherwise stall. In hands-on terms, more reliable downstream coupling and cleaner final deprotection mean cleaner product and less need for labor-intensive re-purification. From our side, the less a client hears from analytical QC during a project, the more they trust the material batch.
Looking at alternatives, the classic unprotected 4-bromo-1H-imidazole or N-methyl analogs promise a quick route but cost time and purity in the long run. N-methylation, in particular, blocks too many downstream modifications for diverse analog work. Other N-substituted imidazoles don’t tolerate deprotection nearly as well; base-sensitive groups fail in the presence of metal catalysts or expose chemists to side product headaches. Our trityl-protected version survives not just acidic but also moderate basic conditions, offering sharper control over each job step. This gives real benefits during route scouting and scale-up, especially where every intermediate costs budget and time.
We keep getting feedback from clients frustrated by off-flavors in other supplier's lots. Weak purification can leave behind not only unreacted starting material but trace trityl alcohols or polymeric byproducts. These silent culprits don’t show up at a glance but show their presence as unexplained TLC spots, stubborn foaming during chromatography, or crash-outs during final crystallization. Over time, we fine-tuned our process, not because some spec forced our hand, but because repeated experience with customer pilot batches taught us where things go wrong.
The trityl group also brings unique handling requirements. It’s more hydrophobic than most nitrogen protecting groups. We package in small, moisture-sealed containers to cut the chances of sticky clumping or slow dissolution in organic solvents. Too large a container allows ambient humidity to creep in, so we invested in more expensive barrier plastics and automated weighing under positive-pressure dry rooms. One-size-fits-all economics never justified the call-backs and returns we endured early on. Changing the packaging for different end-user scales helped chemists working at discovery, process R&D, and pre-clinical stages alike.
Users sometimes underestimate the persistence and ease of trityl removal. Strong mineral acids at room temperature work, but can also generate unwanted salt forms or by-products. Through client collaboration, we found that using a milder acidic resin or low-temperature TFA gives better results, particularly in the late stages of process development where post-synthesis purification has the greatest downstream impact. Sharing these tips came from supporting dozens of customer troubleshooting efforts, not just reading the handbooks.
Another pitfall arrives with attempts to run palladium-catalyzed couplings without accounting for lingering residual trityl alcohol or chloride from earlier stages. Early in our production, a run with inadequate final wash gave us a call from a client struggling with palladium black precipitation. We tested our batch, found a minute trityl chloride contaminant, and improved our crystallization and washing steps the very next week. Direct manufacturer-user relationships expose these sharp learning curves, especially when compared to traders or distributors who miss reactive intermediate quirks.
We also see confusion about storage and long-term stability. There’s a meme that trityl-protected imidazoles survive any room temperature shelf—our experience says otherwise. Even solid, batch-sealed material benefits from cool, desiccated storage. A jar open to the bench shows slow yellowing and reduced recovery in high-sensitivity routes. Here, we offer guidance on splitting batches, using unit-dose vials for active projects, and minimizing open-air handling. We have run forced-aging studies to help guide larger project procurement cycles, ensuring consistency from one purchase to the next, regardless of timing.
Production scale for specialty imidazoles can be modest by commodity standards, but waste still adds up. We’re close enough to our own reactors to know that every unnecessary synthetic step increases both cost and environmental burden. Over-tritylation, inefficient washing, or excessive use of chlorinated solvents haunt process flow diagrams. For us, eliminating even one solvent extraction per batch ends up saving hundreds of liters of waste each year. Doubling efficiency in tritylation by real-time monitoring—rather than relying on time alone—helped prevent excess reagent loss and gave better purity up front.
There’s a temptation to chase ever-higher purity for the sake of numbers. We’ve seen this push cause more solvent use and energy expenditure than the finished batch ever warrants. We learned, through dialogue with downstream analytical chemists, where true specification bottlenecks lie. Sometimes, accepting 99.3% instead of 99.7% purity made for an easier, safer overall workflow. Our lab conversations, not marketing templates, kept us focused on balancing quality, productivity, and sustainability.
We also worked with clients to enable in-house regeneration of trityl reagents, extending the value chain and helping reduce their environmental impact. As more customers ask about the full sustainability of their supply chain, we’re in a position—directly responsible for our synthesis—to document and improve our waste handling and energy use in concrete ways.
The transition from a 10-gram flask setup to a 50-kilo reactor brings challenges invisible to most catalog suppliers. In our experience, temperature profiles must be customized at every scale. Trityl cation liberation, for example, generates more heat than small-scale runs suggest. We assist clients in mapping out calorimetry data, scaling stirring profiles, and adjusting reagent dosing to prevent runaway or incomplete reactions. We have also had to revamp our equipment, adding better real-time temperature and pH monitoring to catch problems before they mushroom.
Washing and isolation take on a new dimension during plant-scale production. We’ve seen how custom filtration media improve the removal of fine trityl residues, which otherwise carry over and challenge crystallization. Process chemists working with us often trial different work-ups side by side, benefiting from our small-batch flexibility to parallel test new protocols before “going big.” This hands-on exchange—comparing laboratory and plant data—helped sharpen our own protocols, reducing the failure rate at the industrial scale and allowing for smoother process transfers from R&D to manufacturing.
Shipping also changes from a routine task to a logistics puzzle at scale. Peroxide formation in bulk storage, risk of moisture ingress, and choices of drum material all play a part in ensuring stability. Our shift to smaller, nested container options reduced the risk of single-batch spoilage. Working directly with users, rather than through abstract supply chains, made it easy to catch these details and fix them proactively.
Regulators and quality auditors want actual traceability, not gloss. We trace our trityl, bromination, and imidazole sourcing all the way back, logging lot-to-lot changes. Early in production, an unexpected change in bromine supplier gave our analysts a surprise shift in impurity profile. The event led us to tighten source auditing and keep greater raw material reserves—less dramatic than advertising, but critical for customers walking into regulatory inspections. We learned fast that documentation and proactive corrective action do more for project reliability than the most elaborate marketing claims.
Safety data evolves over time. Years ago, we flagged an unexpected skin-sensitization complaint traced back to a trace byproduct in the tritylation step. We quickly revised protocols, issued proactive customer notifications, and worked with automotive safety and pharmaceutical clients to confirm improved workplace handling. Listening to actual user feedback, instead of filing regulatory forms and moving on, gave us an edge in trust and repeat business.
The best insights rarely arrive as formal complaints—they show up as emails about stuck crystallizations, stubborn NMR peaks, or product color drifting from white to cream. We hear from both research and process chemists, each with their own set of challenges. Several academic groups found improved downstream selectivity by adjusting their trityl deprotection protocol—a tip that originated from ongoing discussions with another medicinal chemistry partner. These knowledge sharing loops, enabled by our direct involvement, close the gap between manufacturing and applied research.
On one notable occasion, a research group using another supplier’s lot encountered persistent haze and clogging during preparative scale-up. After reviewing their data and comparing analytical results, we provided a sample from our own manufacturing run. Clear improvement followed, saving their project timeline and giving us a chance to refine our own process through their thorough feedback.
Others call to ask how best to rinse trityl byproducts from scale-up glassware or optimize solid transfer to minimize material loss. We continue to adjust our technical bulletins and protocols in real-time, based on these unfiltered conversations—staying flexible instead of rigidly clinging to legacy documentation.
New methodologies in catalysis, protection, and deprotection regularly change the demand for building blocks. We monitor these trends not by browsing journals alone, but through daily orders and special requests. Requests for different lot sizes or faster shipping signal research priorities and help us plan production cycles. We reinvest in staff training, synthesis control, and QA/QC technology—not because brochures demand it, but because chemists using our material prove that predictable outcomes matter more than theoretical yields.
More companies focus on hazard reduction and green chemistry. Sourcing pressure on brominating agents, regulatory scrutiny on protecting group waste, and tighter discharge regulations all influence how we plan our own process upgrades. We’ve set up internal metrics for solvent recovery, reaction atom economy, and reduction of trityl-derived waste, and we hold ourselves accountable by tracking each campaign, learning from unexpected results, and updating protocols for the next batch. As customers ask for greener credentials, we show real, measured progress, rooted in firsthand operational experience.
Supplying 4-Bromo-1-Trityl-1H-Imidazole is more than a catalog number for us. Each batch follows a story of process tuning, end-user dialogue, and iterative improvement. We know how details at the manufacturing bench ripple out in every stage—from discovery to process optimization and final product shipment. Every re-order, technical call, or sample request pushes us to refine both synthesis and support. Our manufacturing roots keep us grounded, committed to real-world chemistry. The hands-on connection to every batch delivers the reliability, transparency, and practical insight that growing labs and established process teams expect from a manufacturer, not just a name stamped on a label.